(June 28, 2019, 11:01 AM EDT) -- WASHINGTON, D.C. — In a June 24 nonconfidential opening appellant brief, Amgen Inc. urges the Federal Circuit U.S. Court of Appeals to put an end to a patent case “that neither party wants to litigate” (Amgen Inc. v. Watson Laboratories Inc., et al., No. 19-1650, Fed. Cir.)....